Results 71 to 80 of about 357 (159)

Brain nitric oxide and inflammation in chronic intermittent hypoxia: Contributors to cognitive impairment and hypertension. [PDF]

Brain Behav Immun Health
Appiah CB, Aikins AO, Farmer GE, Cunningham JT.   +3 more
europepmc   +1 more source

Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data. [PDF]

Ann Intern Med
Portela GT, Carson JL, Swanson SA, Alexander JH, Hébert PC, Goodman SG, Steg PG, Bertolet M, Strom JB, Fergusson DA, Simon T, White HD, Cooper HA, Abbott JD, Rao SV, Chaitman BR, Fordyce CB, Lopes RD, Daneault B, Brooks MM, MINT Investigators.   +20 more
europepmc   +1 more source

The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51. [PDF]

Antimicrob Agents Chemother, 2017
Warrilow AGS, Parker JE, Price CL, Garvey EP, Hoekstra WJ, Schotzinger RJ, Wiederhold NP, Nes WD, Kelly DE, Kelly SL.   +9 more
europepmc   +1 more source

Comparative effects of square-stepping and strengthening exercises on cognitive and balance functions in chronic obstructive pulmonary disease: a randomized clinical trial. [PDF]

PeerJ
Özel A, Tütün Yümin E, Konuk S.
europepmc   +1 more source

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.

JAMA Intern Med, 2022
Chu DK, Abrams EM, Golden DBK, Blumenthal KG, Wolfson AR, Stone CA, Krantz MS, Shaker M, Greenhawt M.   +8 more
europepmc   +1 more source

Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial.

JAMA Netw Open
Carrier FM, Cooper HA, Portela GT, Bertolet M, Lemesle G, Prochaska M, Kim S, Alexander JH, Crozier I, Ducrocq G, Quadros AS, Bagai A, Dracoulakis M, Madan M, Brooks MM, Carson JL, Hébert PC, MINT Investigators.   +17 more
europepmc   +1 more source

"Reasonable adjustments" under the UK's Equality Act 2010: An enquiry into the care and treatment to patients with intellectual disabilities in acute hospital settings. [PDF]

J Appl Res Intellect Disabil, 2019
Redley M, Lancaster I, Pitt A, Holland A, Thompson A, Bradley JR, Glover G, Thomson K, Jones S, Herbert B, Holme A, Clare ICH.   +11 more
europepmc   +1 more source

The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. [PDF]

Antimicrob Agents Chemother, 2016
Warrilow AG, Parker JE, Price CL, Nes WD, Garvey EP, Hoekstra WJ, Schotzinger RJ, Kelly DE, Kelly SL.   +8 more
europepmc   +1 more source